Technical Analysis for XRTXF - Xortx Therapeutics Inc

Grade Last Price % Change Price Change
grade C 0.1097 -24.14% -0.0349
XRTXF closed down 24.14 percent on Thursday, August 1, 2019, on 1.94 times normal volume. The bears made the stock sink to a new 52-week low.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical XRTXF trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
New 52 Week Low Weakness 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -24.14%
Gapped Down Weakness -24.14%
New 52 Week Closing High Bullish -42.78%
Narrow Range Bar Range Contraction -42.78%
New 52 Week High Strength -42.78%
Gapped Up Strength -42.78%

Older signals for XRTXF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
XORTX Therapeutics Inc., a biopharmaceutical company, focuses on developing therapies to treat progressive kidney diseases worldwide. Its lead program develops therapies for the treatment of progressive kidney disease due to diabetes, diabetic nephropathy, and polycystic kidney diseases. The company's program also focuses on developing therapies for health consequences that includes pre-diabetes, diabetes, and cardiovascular disease. In addition, it develops uric acid lowering agents to treat diabetic nephropathy, hypertension, insulin resistance, metabolic syndrome, and diabetes; and xanthine oxidase inhibitors. The company is headquartered in Calgary, Canada.
Medicine RTT Medical Specialties Biopharmaceutical Diabetes Organ Systems Hypertension Cardiovascular Disease Diabetes Mellitus Kidney Kidney Diseases Metabolic Syndrome Endocrine Diseases Insulin Resistance Diabetic Nephropathy Polycystic Kidney Diseases Prediabetes
Is XRTXF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 0.1917
52 Week Low 0.1097
Average Volume 5,400
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1324
Resistance 3 (R3) 0.1349 0.1298 0.1286
Resistance 2 (R2) 0.1298 0.1241 0.1286 0.1273
Resistance 1 (R1) 0.1198 0.1205 0.1173 0.1173 0.1261
Pivot Point 0.1147 0.1147 0.1135 0.1135 0.1147
Support 1 (S1) 0.1047 0.1090 0.1022 0.1022 0.0933
Support 2 (S2) 0.0996 0.1054 0.0984 0.0921
Support 3 (S3) 0.0896 0.0996 0.0908
Support 4 (S4) 0.0871